Revenue

New AI assistants build data pipelines in weeks, not months. But can they be trusted? A look at how Coalesce Copilot embeds governance to win over the enterprise.

Condor Energies secures $10M in a high-stakes financing to fast-track its Uzbekistan gas program. A deep dive into the strategy, risks, and what it means.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

As AI-native fintech Henon plants its flag in London, its push for 'zero-error' finance signals a new competitive era for private capital in EMEA.

A new report shows a startling drop in dental benefits, revealing deep cracks in America's health system and new economic pressures on employers.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

An award for recycling innovation signals a major market shift, as Aurora Material Solutions turns waste PVC into a high-value industrial asset.

A new platform lets your idle devices earn Bitcoin. Is this a futuristic lifestyle trend for luxury living or just a volatile digital experiment?

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

Exodus is using its Bitcoin treasury to buy a payments firm, but declining user metrics and a change in disclosure raise questions about this bold strategy.

With its new CRO from Asana and LinkedIn, HR tech unicorn Lattice is betting on a human-centric AI strategy to dominate the future of performance management.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A logistics firm's stock soared 1,100% then collapsed overnight. Inside the alleged pump-and-dump scheme that reveals deep cracks in market integrity.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Rivals like OpenAI, Google, and Microsoft are joining forces under the Linux Foundation to build open standards for autonomous AI. What does this mean?

Amara Industries' strategic acquisition of Thomson Plastics signals a major shift, creating a tech-forward giant in North American injection molding.